Subtopic Deep Dive
Vascular Closure Devices
Research Guide
What is Vascular Closure Devices?
Vascular closure devices (VCDs) are mechanical systems, including suture-mediated like Perclose Proglide and collagen-based like Angio-Seal VIP, designed to achieve rapid hemostasis after femoral arteriotomy in percutaneous coronary interventions.
Randomized trials demonstrate VCDs reduce time to hemostasis and ambulation compared to manual compression (Martin et al., 2007, CAP trial, 111 citations). They lower vascular complication risks in patients receiving glycoprotein IIb-IIIa inhibitors (Resnic et al., 2001, 91 citations). Failure rates and implications remain critical concerns (Bangalore et al., 2009, 90 citations). Over 1,000 papers reference VCD efficacy in procedural contexts.
Why It Matters
VCDs enable same-day discharge after PCI, reducing hospital costs and patient morbidity (Shroff et al., 2016, 89 citations). In radial access shifts, they complement hemostasis strategies, though femoral VCDs persist for large-bore procedures (Mitchell et al., 2012, 190 citations). Martin et al. (2007) CAP trial showed Proglide and Angio-Seal superior to compression in ambulation time and satisfaction. Resnic et al. (2001) quantified reduced hematomas with VCDs despite antiplatelet therapy, optimizing cath lab workflows.
Key Research Challenges
VCD Failure Rates
Device deployment fails in 8-10% of cases, leading to surgical repair needs (Bangalore et al., 2009, 90 citations). Risk factors include obesity and anticoagulation. Trials report higher pseudoaneurysm incidence versus manual methods.
Complication in Anticoagulated Patients
Glycoprotein IIb-IIIa inhibitors elevate vascular risks despite VCD use (Resnic et al., 2001, 91 citations). Retroperitoneal bleeding persists as a concern. Comparative trials needed for modern regimens.
Cost-Effectiveness Variability
Radial access shows better value than femoral VCDs in systematic reviews (Mitchell et al., 2012, 190 citations). Upfront device costs offset by reduced monitoring time. Long-term data gaps hinder adoption.
Essential Papers
Risks and Complications of Coronary Angiography: A Comprehensive Review
Morteza Tavakol, Salman Ashraf, Sorin J. Brener · 2011 · Global Journal of Health Science · 374 citations
Coronary angiography and heart catheterization are invaluable tests for the detection and quantification of coronary artery disease, identification of valvular and other structural abnormalities, a...
Transradial arterial access for coronary and peripheral procedures: Executive summary by the transradial committee of the SCAI
Ronald Caputo, Jennifer A. Tremmel, Sunil V. Rao et al. · 2011 · Catheterization and Cardiovascular Interventions · 302 citations
Abstract In response to growing U.S. interest, the Society for Coronary Angiography and Interventions recently formed a Transradial Committee whose purpose is to examine the utility, utilization, a...
Systematic Review and Cost–Benefit Analysis of Radial Artery Access for Coronary Angiography and Intervention
Matthew D. Mitchell, Jaekyoung Hong, Bruce Y. Lee et al. · 2012 · Circulation Cardiovascular Quality and Outcomes · 190 citations
Background— Radial artery access for coronary angiography and interventions has been promoted for reducing hemostasis time and vascular complications compared with femoral access, yet it can take l...
Distal Versus Conventional Radial Access for Coronary Angiography and Intervention
Adel Aminian, Gregory A. Sgueglia, Marcus Wiemer et al. · 2022 · JACC: Cardiovascular Interventions · 135 citations
Distal transradial access in the anatomical snuffbox for diagnostic cerebral angiography
Marie-Christine Brunet, Stephanie H. Chen, Samir Sur et al. · 2019 · Journal of NeuroInterventional Surgery · 123 citations
Background The transradial approach for endovascular angiography and interventional procedures is superior to the traditional transfemoral approach in several metrics, including lower access-site c...
Radial artery access for coronary angiography and percutaneous coronary intervention
Andrew Archbold, Nicholas Robinson, Richard J. Schilling · 2004 · BMJ · 114 citations
Abnormal liver function after an unplanned consultationThis case was described on 31 July and 7 August (BMJ 2004;329, 273 and 342).Debate on the management of the patient continues on bmj.com/cgi/c...
A randomized trial comparing compression, perclose proglide™ and Angio‐Seal VIP™ for arterial closure following percutaneous coronary intervention: The cap trial
Jack L. Martin, Antonis Pratsos, Edward Magargee et al. · 2007 · Catheterization and Cardiovascular Interventions · 111 citations
Abstract Objective: This prospective randomized trial compared the Angio‐Seal VIP™ with Perclose Proglide™ and to manual compression with respect to time to hemostasis and ambulation, patient satis...
Reading Guide
Foundational Papers
Start with Martin et al. (2007) CAP trial for direct Proglide vs Angio-Seal vs compression RCT (111 citations), then Tavakol et al. (2011) for angiography risks overview (374 citations), and Resnic et al. (2001) for VCDs under IIb-IIIa inhibitors.
Recent Advances
Study Shroff et al. (2016) on same-day PCI discharge enabled by VCDs (89 citations), and Aminian et al. (2022) contrasting distal radial access (135 citations) as VCD alternative.
Core Methods
Core techniques: randomized hemostasis trials measuring ambulation time (Martin 2007); failure rate analysis via deployment logs (Bangalore 2009); cost-benefit modeling with radial comparisons (Mitchell 2012).
How PapersFlow Helps You Research Vascular Closure Devices
Discover & Search
Research Agent uses searchPapers('vascular closure devices Perclose Proglide failure rates') to retrieve Bangalore et al. (2009), then citationGraph reveals 90 citing papers on implications, while findSimilarPapers expands to Resnic et al. (2001) for complication risks.
Analyze & Verify
Analysis Agent applies readPaperContent on Martin et al. (2007) CAP trial to extract hemostasis times, verifyResponse with CoVe cross-checks claims against Tavakol et al. (2011), and runPythonAnalysis computes meta-analysis odds ratios from trial data using pandas for complication rates, graded via GRADE for evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in VCD failure predictors from Bangalore et al. (2009) versus radial shifts in Caputo et al. (2011), while Writing Agent uses latexEditText for trial comparison tables, latexSyncCitations integrates 10 papers, and latexCompile generates a review manuscript with exportMermaid for hemostasis workflow diagrams.
Use Cases
"Extract complication rates from VCD trials and run meta-analysis."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on rates from Martin 2007, Resnic 2001) → CSV export of forest plot statistics.
"Write LaTeX review comparing Proglide vs Angio-Seal in PCI."
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/results) → latexSyncCitations (CAP trial) → latexCompile → PDF with cited figures.
"Find code for simulating VCD hemostasis models from papers."
Research Agent → paperExtractUrls (Mitchell 2012 cost models) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on repo scripts for cost-benefit simulations.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ VCD papers) → citationGraph → GRADE grading → structured report on efficacy (Martin 2007 benchmarked). DeepScan applies 7-step analysis with CoVe checkpoints on Tavakol et al. (2011) complications versus Resnic et al. (2001). Theorizer generates hypotheses on distal radial VCD adaptations from Aminian et al. (2022).
Frequently Asked Questions
What defines vascular closure devices?
VCDs include suture-based (Perclose Proglide) and collagen-plug (Angio-Seal VIP) systems for post-PCI femoral hemostasis, outperforming manual compression in ambulation time (Martin et al., 2007).
What methods compare VCDs?
Randomized trials like CAP (Martin et al., 2007, 111 citations) test time-to-hemostasis, ambulation, and complications against compression; radial access meta-analyses benchmark costs (Mitchell et al., 2012).
What are key papers on VCDs?
Martin et al. (2007) CAP trial (111 citations) favors Proglide/Angio-Seal; Bangalore et al. (2009, 90 citations) analyzes failures; Resnic et al. (2001, 91 citations) addresses antiplatelet risks.
What open problems exist in VCD research?
VCD failures in anticoagulated patients persist (Bangalore et al., 2009); cost-effectiveness lags radial methods (Mitchell et al., 2012); large-bore arteriotomy data gaps remain.
Research Vascular Procedures and Complications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Vascular Closure Devices with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers